Journal of Clinical and Cosmetic Dermatology最新文献

{"title":"Surgical Treatment for Epiphora: Do not Overlook the Lacrimal Gland","authors":"J. Schwember, C. Barria, L. Madrid, L. Yori, F. Bustamante","doi":"10.16966/2576-2826.137","DOIUrl":"https://doi.org/10.16966/2576-2826.137","url":null,"abstract":"Epiphora is a condition resulting from Hyper-secretion of Tears (HT) from the lacrimal gland, eyelid malposition, obstruction or absence of lacrimal ducts and treatment will vary according to the etiology. This article describes the author’s results of a Partial Ablation of the Orbital Portion of the lacrimal gland (PAOP) under local anesthesia. Twelve adult patients, six diagnosed with HT and six with a previous dacryocystectomy, underwent surgery performed by a single surgeon in his office setting between the years 2011-2017. The average follow-up lasted 14 months, ranging from six months to three years. All patients fully recovered without any other medical or surgical intervention. Two patients experienced dry eye symptoms during the first three months after surgery but experienced relief with ocular lubricants.","PeriodicalId":281715,"journal":{"name":"Journal of Clinical and Cosmetic Dermatology","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126345250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"HA Fillers: A New “Tool” to Face Facial Post Surgical Deformities?","authors":"R. Rauso","doi":"10.16966/2576-2826.146","DOIUrl":"https://doi.org/10.16966/2576-2826.146","url":null,"abstract":"hemifacial microsomia, and posttraumatic or postsurgical craniomaxillofacial deformity reconstruction. The hypothesis is based on the concept that the volumizing effects result from tissue induction through activation of periosteum-resident stem cells. One clinical example, explaining our hypothesis, is cauliflower ear, a condition caracthreized by hypertrophied tissue developed after repeated traumatic hematoma in the auricle [4].","PeriodicalId":281715,"journal":{"name":"Journal of Clinical and Cosmetic Dermatology","volume":"12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122282734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Preliminary Report on the Safety and Efficacy of a Novel MaiLi HA Filler for Facial Correction of Wrinkles, Folds, Volume and Lips","authors":"Micheels P, Poiraud M","doi":"10.16966/2576-2826.175","DOIUrl":"https://doi.org/10.16966/2576-2826.175","url":null,"abstract":"Introduction: The principal author was given the opportunity to assess new hyaluronic acid filler, first before its European Commission labeling during clinical investigations in France, and then after its European Commission labeling in his clinical practice in Geneva, Switzerland. This hyaluronic acid gel benefits from the world’s first patented OxiFree™ technology. This article sought to present preliminary safety and efficacy data from the first private patient series treated in Geneva with this cross-linked hyaluronic acid gel, called MaiLi. Material and methods: Like most of its competitors, MaiLi is available in various variants, including gel for filling fine wrinkles, for deeper wrinkles, folds, and for lip enhancement, in addition to gels for volumizing indications. This cohort study encompassed patients from the authors’ private esthetic clientele in Geneva, Switzerland. Depending on the indications, the injections were performed according to previously described techniques, ranging from the “blanching technique” to deeper injections. Results: Between January and November 2021, overall 45 patients aged 56 years on average were injected MaiLi gels, according to the areas they wished to be treated, with a follow-up period ranging from a few days to 12 months. Based on our current dataset, we confirm that MaiLi fillers have proven very safe, causing no unexpected undesirable effects. The gel’s hold over time related to its remarkable projection capacity was excellent, resulting in quite natural outcomes and a perfect integration into the tissues. These beneficial effects were still evident at 1-year follow-up. Conclusion: The MaiLi hyaluronic acid fillers proved to be well tolerated and safe, with long-lasting effects. Remarkable properties revealed in this follow-up were their projection capacity and suppleness, as well as their ease of use and longevity, resulting in full patient satisfaction. No relevant undesirable effects were observed. There were no edematous reactions following the injections, nor were there any lymphatic circulation disorders.","PeriodicalId":281715,"journal":{"name":"Journal of Clinical and Cosmetic Dermatology","volume":"12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123828221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cross-Sectional Study Design and Data Analysis of the Effect of Chitin NanofibrilsLignin Micro/Nano Particles on Malaysia’s Subjects with Skin Disorders","authors":"Jui Yy, Ching Tl, Ing Ts, Cardillo M, Gagliardini A, M. P","doi":"10.16966/2576-2826.139","DOIUrl":"https://doi.org/10.16966/2576-2826.139","url":null,"abstract":"Objective: The Objective of the paper is to control the activity of innovative Cosmetic products, classified as Cosmeceuticals because of their particular effectiveness and used alone without consume of drugs, to verify their efficacy on subjects affected by acne, contact dermatitis, and photoaging. After an introduction reporting some data on the cosmetic market in Malaysia and their habit of mind to attend the Beauty Centers before going to dermatologist, we report the method of treatment by cosmetic products organized by 90 voluntary subjects, divided in three groups of 30 subjects, affected by photo-aging, acne and contact dermatitis respectively. They were treated for 90 days and two times a week into a Malaysian Beauty center by different Cosmetic emulsions based on the use of chitin nanofibrils-lignin micro/nanoparticles bound to different selected active ingredients, such as nicotinamide, antioxidants and glycolic acid. The same products were used at home in the morning and evening for all the in study period. Treatments into the Beauty Center and at home were under the control of a Dermatologist and expert beauticians for all the period of experimentation and the control was verified by the score method and photosat the starting day and after 30, 60, 90 days of treatment and 120 days (follow up visit). The obtained results, controlled by a dermatologist by score methods and photos, have shown the possibility to use well formulated cosmetics to try to ameliorate the reported diseases, without the use of topical and/or systemic drugs. In conclusion, these innovative cosmeceutical, used by the help of expert beauticians, may be of great help to Dermatologists and Plastic surgeons to solve some skin problems, avoiding the use of drugs, or limiting their doses to lessen the risk of harmful side effects.","PeriodicalId":281715,"journal":{"name":"Journal of Clinical and Cosmetic Dermatology","volume":"96 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124690487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of the Efficacy and Safety of A New Pigment Correction Cosmetic Protocol in Caucasian Women with Melasma","authors":"Catala A, G. C, V. M","doi":"10.16966/2576-2826.176","DOIUrl":"https://doi.org/10.16966/2576-2826.176","url":null,"abstract":"Melasma is one of the most prevalent acquired pigmentation disorders, especially among women due to its hormonal background. There is a wide variety of therapeutic alternatives available for its treatment given its multifactorial origin and complexity. Cosmetic protocols based on depigmenting agents remain one of the cornerstones of melasma treatment. Aim: To evaluate the efficacy and safety of a new cosmetic pigment correction protocol in the treatment of melasma in Caucasian women. Methods: A single-blind, prospective, single-center study was conducted in 20 women between 25 and 65 years of age, phototypes II-IV with mildmoderate facial melasma. For 90 days patients applied a sunscreen and moisturizing cream in the morning and a pigment correction protocol at night consisting of a skin retinization regime combining two formulations with Retinsphere® technology. (Neoretin DC Ultra emulsion and Neoretin DC transition cream). Treatment results were evaluated by clinical assessment, Observ® photography and non-invasive instrumental measurements such as the erythema and melanin index by Mexameter. The Melasma Area and Severity Index (MASI) were recorded, and patients completed both a quality of life questionnaire (MELASQoL) and a subjective evaluation. Results: MASI score was significantly reduced at all study visits, with a significant reduction in the area and severity of melasma already observed at 30 days and a 48% reduction at the end of treatment. In the opinion of the investigator and patients, some degree of improvement was reported in 95% of patients at the end of treatment and neither patients nor the investigator reported worsening of melasma at the end of treatment as compared to baseline. The degree of melasma improvement observed by patients increased progressively and significantly from day 45 onwards, reaching an improvement of almost 70% at the end of the treatment. The adverse effects evaluated, (peeling, erythema, burning, tightness, irritation, and itching) increased gradually, being higher at T45 and T60, coinciding with the greater frequency of application of the formulations. Effects were however transient and in no case reached statistical significance or required treatment discontinuation. Conclusion: The cosmetic pigment correction protocol under study appears to be an effective therapeutic option for the treatment of melasma. The retinization regime, which consisted in the gradual application of the more powerful formulation alternated with a transition formulation, made it possible to achieve both efficacy and good tolerability to the therapeutic regimen.","PeriodicalId":281715,"journal":{"name":"Journal of Clinical and Cosmetic Dermatology","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127942871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Novel Combination Therapy in Aesthetic and Reconstructive Surgery: Sea Salt Exfoliation, Cavitating Ultrasound, and High Intensity Multiwavelength LED Treatment: (SaltFacial)","authors":"Chernoff G","doi":"10.16966/2576-2826.162","DOIUrl":"https://doi.org/10.16966/2576-2826.162","url":null,"abstract":"Introduction: The science in aesthetic medicine continues to grow and expand exponentially. With improved science comes advanced clinical therapeutics that further benefits our patients. Physicians are seeking non-surgical technologies that are capable of safely treating all Fitzpatrick skin types while yielding meticulous results.","PeriodicalId":281715,"journal":{"name":"Journal of Clinical and Cosmetic Dermatology","volume":"45 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129100179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Objective Evaluation of the Longevity of A Calcium Hydroxylapatite-Based Filler (Radiesse®)","authors":"A. M.","doi":"10.16966/2576-2826.163","DOIUrl":"https://doi.org/10.16966/2576-2826.163","url":null,"abstract":"Background: Calcium hydroxylapatite (CaHA) based soft-tissue filler (Radiesse® , Merz) is categorised as a biodegradable collagen-stimulating implant. It is comprised of a suspension of 25-45 micron diameter microspheres of CaHA(30%) in a carboxymethylcellulose (CMC) gel carrier (70%) and is one of the most well researched soft-tissue fillers. However, great discrepancies exist in the literature regarding the duration of clinical effect with the implant, ranging from only 6 to 24 months.","PeriodicalId":281715,"journal":{"name":"Journal of Clinical and Cosmetic Dermatology","volume":"79 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130800412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of the Effects of a New Cosmetic Protocol based on the Application of a Home Peel with 1% Retinol","authors":"Truchuelo Mt, B Hashtroody, M. Vitale","doi":"10.16966/2576-2826.142","DOIUrl":"https://doi.org/10.16966/2576-2826.142","url":null,"abstract":"Introduction: The main purpose of this study was to determine the safety and tolerance of a new cosmetic procedure based on the use of a Home Peel with 1% retinol. Secondly, the subjective efficacy was evaluated. The treatment was to be considered well-tolerated if it permitted recovery of Trans Epidermal Water Loss (TEWL) within a few days following the procedure and if patients reported no significant adverse effects. This new protocol was to be judged effective if it improved clinical alterations associated with photoaging. Methods: 6 subjects (45 years, Female) with moderate aging were treated with a protocol that included a home peel applied twice daily for 3 days. The protocol included a preparatory and post-procedure period. Pictures to enable clinical evaluation were taken with a Reveal® evice and TEWL was assessed by Tewameter® . The subjective evaluation of the subjects and clinical improvement from the investigator was also registered. Results: A moderate improvement described by both investigator and patients was observed in 83% of subjects. Tolerance was excellent, with low grade of desquamation, erythema and burning sensation after the preparation phase (T0) and immediately following the home peel (T3). Conclusion: A new protocol including a home peel product with retinol demonstrated to be safe and effective in the management of skin aging. Improvement in the signs of aging was perceived by both patients and the investigator, with excellent tolerance.","PeriodicalId":281715,"journal":{"name":"Journal of Clinical and Cosmetic Dermatology","volume":"46 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132641003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Skin Alterations Caused by Chemotherapies and Cosmetic Strategies for Soothing These Effects: A Review","authors":"Moreira Al, F. hr, Portilho L","doi":"10.16966/2576-2826.166","DOIUrl":"https://doi.org/10.16966/2576-2826.166","url":null,"abstract":"Cancer is a set of more than one hundred diseases caused by the development of malignant tumors, formed by cells that stand out for their uncontrolled division, altered response to growth factors, increased longevity, changes in function and structure, less intracellular adhesion and ability to invade other tissues in the body. One of the most used treatments currently against these diseases is chemotherapy. It attacks cells that have high rates of division and, therefore, its side effects are felt especially in tissues that naturally present this characteristic, such as skin, nails and hair. Since the affected tissues are deeply linked to beauty and self-esteem, it is necessary to seek alternatives to mitigate the negative effects of the treatment to increase the quality of life of the patients subjected to it. Based on this theme, the objective of this study is to review the physiology of the skin, how malignant tumors appear, the cutaneous side effects of chemotherapy treatments, cosmetic actives present in the Brazilian market indicated to alleviate these effects and suggest the formulation of products for palliative treatment of patients undergoing cancer treatment.","PeriodicalId":281715,"journal":{"name":"Journal of Clinical and Cosmetic Dermatology","volume":"106 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115571360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Perifolliculitis Capitis Abscedens Et Suffodiens: A Case Report and Literature Review","authors":"Valencia Vg, Malliquinga Ms, M. Rr, Santamaria Fep","doi":"10.16966/2576-2826.167","DOIUrl":"https://doi.org/10.16966/2576-2826.167","url":null,"abstract":"Dissecting cellulitis of the scalp is a rare inflammatory disorder of unknown etiology. It is clinically characterized by the formation of painful suppurative chronic nodules and abscesses, which are connected by fistulae that, although they can be cured, as a consequence leave patients with irreversible alopecia. Currently, there are only a few cases reported in the literature. Here we present the case of a 45-year-old patient with dissecting cellulitis of the scalp, focusing on the histopathological findings and clinicopathologic correlation.","PeriodicalId":281715,"journal":{"name":"Journal of Clinical and Cosmetic Dermatology","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116404049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}